Venetoclax in Immunoglobulin Light Chain Amyloidosis: Is This the Beginning or the End?
Immunoglobulin light chain amyloidosis (AL) is a plasma cell (PC) dyscrasia characterized by a neoplastic malignant PC population producing highly toxic light chains. Despite overlapping features with multiple myeloma (MM), therapeutic options are limited as a result of disease-specific treatment toxicities. Given delays in diagnosis, patients often present with advanced disease, making them poor candidates for autologous stem-cell transplantation.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Vikram Premkumar, Raymond Comenzo, Suzanne Lentzsch Tags: Case Report Source Type: research
More News: Amyloidosis | Cancer & Oncology | Hematology | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Toxicology | Transplants